This Article Order Full text via Infotrieve Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Arber, D. A. Articles by Slovak, M. L. Search for Related Content PubMed PubMed Citation Articles by Arber, D. A. Articles by Slovak, M. L.

American Journal of Pathology, Vol 149, 1105-1110, Copyright © 1996 by American Society for Investigative Pathology

REGULAR ARTICLES

CD79 alpha expression in acute myeloid leukemia. High frequency of expression in acute promyelocytic leukemia

DA Arber, KA Jenkins and ML Slovak
Division of Pathology, City of Hope National Medical Center, Duarte, California 91010, USA.

CD79 alpha is a subunit of an intracytoplasmic protein reported to be specific for B lymphocytes, including immature B lineage cells. To evaluate expression of the CD79 alpha antigen in acute myeloid leukemia (AML), we studied forty-eight cases of AML by paraffin section immunohistochemistry. The cases included four MO, nine M1, nine M2, ten M3, ten M4, and six M5 AMLs using criteria of the French-American- British cooperative group. Eleven cases demonstrated cytoplasmic staining for the CD79 alpha antigen, including one M1, nine M3, and one M5 AML. These CD79 alpha-positive cases represented 5% of all non- promyelocytic AMLs and 90% of all acute promyelocytic leukemias studied. All acute promyelocytic leukemias had the characteristic t(15;17)(q24;q21), including two cases of the microgranular variant (M3v). No other B-lineage-associated antigens were found in the CD79 alpha-positive cases, with the exception of a subpopulation of CD19- positive leukemic cells in one patient. The two non-promyelocytic leukemias that expressed CD79 alpha had no evidence of t(15;17) and did not express any additional B-lineage-associated antigens that might suggest a mixed lineage proliferation. This study demonstrates that CD79 alpha expression in acute leukemia is not restricted to B-lineage acute lymphoblastic leukemias and that CD79 alpha expression is frequently associated with t(15;17) acute myeloid leukemia.

This article has been cited by other articles:

				E. Tiacci, S. Pileri, A. Orleth, R. Pacini, A. Tabarrini, F. Frenguelli, A. Liso, D. Diverio, F. Lo-Coco, and B. Falini PAX5 Expression in Acute Leukemias: Higher B-Lineage Specificity Than CD79a and Selective Association with t(8;21)-Acute Myelogenous Leukemia Cancer Res., October 15, 2004; 64(20): 7399 - 7404. [Abstract] [Full Text] [PDF]

				M. N. Dworzak, G. Fritsch, G. Froschl, D. Printz, and H. Gadner Four-Color Flow Cytometric Investigation of Terminal Deoxynucleotidyl Transferase-Positive Lymphoid Precursors in Pediatric Bone Marrow: CD79a Expression Precedes CD19 in Early B-Cell Ontogeny Blood, November 1, 1998; 92(9): 3203 - 3209. [Abstract] [Full Text] [PDF]